BioCam Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 40

Employees

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $1.39M

  • Investors
  • 11

BioCam General Information

Description

Developer of an endoscopic capsule designed to reduce the cost of gastrointestinal examinations and increase patient comfort. The company offers local drug-releasing, AI imaging software, and advanced electro-optics, allowing for non-invasive capsule endoscopy examination, enabling doctors to get access to real-time imaging and precise clinical results.

Contact Information

Website
www.biocam.pl
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Rybacka 7/300
  • Wroclaw, 53-656
  • Poland
+48 668
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Corporate Office
  • Rybacka 7/300
  • Wroclaw, 53-656
  • Poland
+48 668

BioCam Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioCam Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Angel (individual) 14-Aug-2025 $1.39M Completed Generating Revenue
9. Grant Completed Generating Revenue
8. Early Stage VC 23-Nov-2023 Completed Generating Revenue
7. Accelerator/Incubator 27-Sep-2023 Completed Generating Revenue
6. Accelerator/Incubator 12-Jul-2023 Completed Generating Revenue
5. Early Stage VC 01-Mar-2023 Completed Generating Revenue
4. Grant 31-Oct-2021 Completed Generating Revenue
3. Early Stage VC 12-Oct-2021 Cancelled Generating Revenue
2. Seed Round 08-May-2020 $272K $272K Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view BioCam’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

BioCam Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioCam Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Angel (individual) Minority
SMOK Angels Angel Group Minority
Angel (individual) Minority
Smartlink Partners Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

BioCam FAQs

  • When was BioCam founded?

    BioCam was founded in 2019.

  • Where is BioCam headquartered?

    BioCam is headquartered in Wroclaw, Poland.

  • What is the size of BioCam?

    BioCam has 40 total employees.

  • What industry is BioCam in?

    BioCam’s primary industry is Diagnostic Equipment.

  • Is BioCam a private or public company?

    BioCam is a Private company.

  • What is BioCam’s current revenue?

    The current revenue for BioCam is .

  • How much funding has BioCam raised over time?

    BioCam has raised $2.84M.

  • Who are BioCam’s investors?

    , , SMOK Angels, , and Smartlink Partners are 5 of 11 investors who have invested in BioCam.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process